PAVmed PAVM
NASDAQ PAVM
$5.23 +0.13 (+2.55%)
At close: Aug 20, 2026 · 11:06 AM UTC

PAVmed (PAVM) Non Operating Investment Income (2024 - 2026)

PAVmed (PAVM) posted quarterly Non Operating Investment Income of $2.5 million for Q4 2025, up 1903.2% year-over-year from $125000.0 in Q4 2024, and up 157.14% quarter-over-quarter from -$4.4 million in Q3 2025.

PAVmed (PAVM) Non Operating Investment Income (2024 - 2026) Analysis & Trends

PAVmed's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $2.5 million for Q4 2025.

  • In Q4 2025, Non Operating Investment Income rose 1903.2% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $8.5 million (changed N/A YoY), while the FY2025 annual figure was $8.5 million, up 1494.55% from the prior year.
  • Non Operating Investment Income for Q4 2025 stood at $2.5 million, up from -$4.4 million in the prior quarter.
  • The five-year high for Non Operating Investment Income was $21.0 million in Q1 2025, with the low at -$10.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn -
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn -
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn -
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn -
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn -
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn -
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn -
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn -
10 PAVmed 32.79 Mn 29.00 Mn -89,000.00 -2.50 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.50 Mn
Jun 30, 2026 -2.50 Mn
Dec 31, 2025 2.50 Mn
Dec 31, 2025 2.50 Mn
Sep 30, 2025 -4.38 Mn
Sep 30, 2025 -4.38 Mn
Jun 30, 2025 -10.64 Mn
Jun 30, 2025 -10.64 Mn
Mar 31, 2025 21.00 Mn
Mar 31, 2025 21.00 Mn
Dec 31, 2024 125,000.00
Dec 31, 2024 125,000.00